403 related articles for article (PubMed ID: 28832164)
1. Tumor-Targeting Micelles Based on Linear-Dendritic PEG-PTX
Zhang Y; Lu Y; Zhang Y; He X; Chen Q; Liu L; Chen X; Ruan C; Sun T; Jiang C
Mol Pharm; 2017 Oct; 14(10):3409-3421. PubMed ID: 28832164
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
3. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
4. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
5. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
6. RGD peptide-decorated micelles assembled from polymer-paclitaxel conjugates towards gastric cancer therapy.
Shi J; Liu S; Yu Y; He C; Tan L; Shen YM
Colloids Surf B Biointerfaces; 2019 Aug; 180():58-67. PubMed ID: 31028965
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of APRPG-modified angiogenic vessel targeting micelles for anticancer therapy.
Guo P; Song S; Li Z; Tian Y; Zheng J; Yang X; Pan W
Int J Pharm; 2015; 486(1-2):356-66. PubMed ID: 25840274
[TBL] [Abstract][Full Text] [Related]
8. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
9. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
10. PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.
Shu X; Zhu Z; Cao D; Zheng L; Wang F; Pei H; Wen J; Yang J; Li D; Bai P; Tang M; Ye H; Peng A; Li W; Chen L
Colloids Surf B Biointerfaces; 2019 Oct; 182():110356. PubMed ID: 31319226
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H
Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170
[TBL] [Abstract][Full Text] [Related]
12. Linear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancer.
Li J; Jiang X; Guo Y; An S; Kuang Y; Ma H; He X; Jiang C
Bioconjug Chem; 2015 Mar; 26(3):418-26. PubMed ID: 25675244
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma.
Pei Q; Hu X; Liu S; Li Y; Xie Z; Jing X
J Control Release; 2017 May; 254():23-33. PubMed ID: 28359677
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
17. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
[TBL] [Abstract][Full Text] [Related]
18. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
[TBL] [Abstract][Full Text] [Related]
19. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
[TBL] [Abstract][Full Text] [Related]
20. Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer.
Peng J; Chen J; Xie F; Bao W; Xu H; Wang H; Xu Y; Du Z
Biomaterials; 2019 Nov; 222():119420. PubMed ID: 31445322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
